1 / 4

Case presented by Dr Polkinghorn

Case presented by Dr Polkinghorn. 65 yo woman with obstructive colon CA  emergency diverting colostomy 7/2009: Found to have synch but isolated liver mets FOLFOX/bevacizumab with significant response  some RFA of liver mets + reversal of colostomy

marjean
Download Presentation

Case presented by Dr Polkinghorn

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case presented byDr Polkinghorn • 65 yo woman with obstructive colon CA  emergency diverting colostomy • 7/2009: Found to have synch but isolated liver mets • FOLFOX/bevacizumab with significant response  some RFA of liver mets+ reversal of colostomy • Postoperative complications (liver abscess requiring drainage) • ? Recurrent vs residual lesion in liver • After healing, restarted on capecitabine/bevacizumab

  2. Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08 Allegra CJ et al. J Clin Oncol 2011; 1(29); 11-16 Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next? Eric Van Cutsem et al. J Clin Oncol 2011; 1(29); 1-4

  3. AVANT: Results from a Randomized, Three-Arm Multinational Phase III Study to Investigate Bevacizumab with Either XELOX or FOLFOX4 vs FOLFOX4 Alone as Adjuvant Treatment for Colon Cancer De Gramont A et al. Proc GICancersSymposium 2011;Abstract 362.

  4. Case presented byDr Polkinghorn 65 yo woman with obstructive colon CA  emergency diverting colostomy 7/2009: Found to have synch but isolated liver mets FOLFOX/bevacizumab with significant response  some RFA of liver mets+ reversal of colostomy Postoperative complications (liver abscess requiring drainage) ? Recurrent vs residual lesion in liver After healing, restarted on capecitabine/bevacizumab

More Related